RT @philipcrobinson: The phase 3 data on secukinumab in #ankylosing #spondylitis looks good, esp. In TNF failures #ACR14 http://t.co/1QRwFb… — Philip Robinson (@philipcrobinson) November 16, 2014
RT @philipcrobinson: The phase 3 data on secukinumab in #ankylosing #spondylitis looks good, esp. In TNF failures #ACR14 http://t.co/1QRwFb…